Ingredients and solutions for the food industry
Microorganisms and active ingredients for human health
Lactic acid bacteria for the agri-veterinary sector

Sacco System Holding srl is born

01/07/2021

Almost five years after the creation of the Sacco System business network, today we are glad to communicate the birth of Sacco System Holding srl: a new corporate structure for which the Verga family plans to forge additional group synergies with a view to achieving structured international growth within the next few years.

Currently, the group includes four companies – Caglificio Clerici spa, Sacco srl, Centro Sperimentale del Latte srl, and Kemikalia AB.
With this new corporate structure, it intends to face the challenge of development at an international level, placing itself in the market with an even greater value not only in terms of economic activity and equity, but also of brand and therefore of business.

The increasingly open desire for innovation and international growth has led the owners to implement this new corporate structure without precluding other choices in the future.

With an aggregate turnover of more than 130 million euros, the companies headed by Sacco System Holding srl, have been able to conquer increasingly dominant positions in the market of enzymes, bacteria and probiotic cultures.

The people of Sacco System will continue to be fundamental in achieving the ambitious goals of the next years, positioning themselves in the biotechnology market in a profitable way with an increasingly stronger and more recognizable brand.

Sacco System: International group, Family spirit.

Latest News

04 September 2026
CSL USA expands its probiotic manufacturing capabilities with integrated encapsulation and packaging

CSL USA Inc., a Sacco System company, is expanding its manufacturing facility in Franksville, Wisconsin, with new fully automated encapsulation and bottle packaging capabilities. The investment further strengthens CSL USA’s

19 March 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 January 2026
SYNBIO: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

22 December 2025
Sacco System grows in Latin America: BioInsumos in Uruguay and Sacco Brasil acquired.

The Group is accelerating its South American growth strategy through a twofold transaction: the acquisition of a Uruguayan company and the full absorption of its Brazilian subsidiary. The Group is

11 December 2025
Sacco System Presents PerforMilk®: Unlocking Milk’s Full Potential by Preserving Protein Quality 

Milk is the most precious resource in dairy production. High-quality dairy products start with high-quality milk—and in today’s rapidly evolving dairy landscape, protecting that quality has never been more critical. 

20 November 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 February 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 January 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 November 2024
News
Our 2023 sustainability report is online!

We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved and the challenges ahead…

16 April 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland…

26 March 2024
News
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici…

18 March 2024
News
List Biotherapeutics and Sacco System Announce Lead Share Agreement

List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement…